[Studies on the androgen-binding proteins in human benign prostatic hypertrophy].

Area of Science:

• Biochemistry
• Molecular Endocrinology
• Urology

Context:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Androgen-binding proteins play a crucial role in mediating the effects of androgens, such as dihydrotestosterone (DHT), in prostate tissue.
• Understanding the characteristics and regulation of these proteins is vital for BPH research.

Purpose:

• To investigate the properties and specificity of androgen-binding proteins in human benign prostatic hypertrophic tissue.
• To examine the influence of divalent cations (Ca2+ and Mg2+) on androgen-DHT and androgen-R1881 binding.
• To characterize the binding proteins using techniques like Scatchard analysis and Sephadex G-200 chromatography.

Summary:

• Scatchard analysis revealed saturable binding proteins with high affinity for 3H-DHT and 3H-R1881 in prostatic cytosol.
• Competitive binding assays demonstrated specificity for DHT or R1881.
• Sephadex G-200 chromatography indicated distinct elution profiles for DHT and R1881 binding.
• Divalent cations (Ca2+, Mg2+) differentially affected binding: Ca2+ and Mg2+ increased DHT binding while decreasing R1881 binding, with Ca2+ showing a more pronounced effect.
• These ionic interactions suggest a modulation of androgen-binding protein properties.

Impact:

• The study identifies specific characteristics of androgen-binding proteins in BPH tissue.
• It highlights the significant role of Ca2+ and Mg2+ in modulating androgen-binding protein activity.
• Findings suggest the presence of a cytosol substance that alters binding protein properties in a Ca2+-dependent manner, offering potential therapeutic targets for BPH.